Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Panacea Biotec Ltd. Capital/Financing Update 2019

Apr 9, 2019

62573_rns_2019-04-09_34058ba3-d059-4032-a931-6a0407821a73.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [61 x 5] intentionally omitted <==

==> picture [159 x 17] intentionally omitted <==

S.No. Particulars Description
I. Reasons for opting for In order to resolve the current debt positionofthe
OTS Company.
2. Briefsummaryofthe All consortium lenders have approved the bilateral OTS at
OTS 65%oftheir outstanding debts.